用于COVID-19相关合并感染和肠道症状的载头孢克洛一水合物结肠靶向纳米颗粒：制剂、表征、释放动力学及抗菌活性
Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity.
作者信息
Alper Öztürk A, Namlı İrem, Aygül Abdurrahman
机构信息
Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Department of Pharmaceutical Technology, Graduate School of Health Sciences, Anadolu University, Eskişehir, Turkey.
出版信息
Assay Drug Dev Technol. 2021 Apr;19(3):156-175. doi: 10.1089/adt.2020.1014. Epub 2021 Mar 15.
PMID:33728979
Abstract
Staphylococcus aureus Escherichia coli co ( S. aureus E. coli
摘要
金黄色葡萄球菌 大肠杆菌 共（金黄色葡萄球菌 大肠杆菌） （这段原文表述似乎不太准确完整，翻译出来有些费解）
Zotero 插件